Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1) ; volume:10 ; number:1 ; day:7 ; month:5 ; year:2020 ; pages:1-13 ; date:12.2020
EJNMMI Research ; 10, Heft 1 (7.5.2020), 1-13, 12.2020
- Creator
-
Yeh, Mei-Chun
Tse, Brian W. C.
Fletcher, Nicholas L.
Houston, Zachary H.
Lund, Maria
Volpert, Marianna
Stewart, Chelsea
Sokolowski, Kamil A.
Jeet, Varinder
Thurecht, Kristofer J.
Campbell, Douglas H.
Walsh, Bradley J.
Nelson, Colleen C.
Russell, Pamela J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-020-00637-x
- URN
-
urn:nbn:de:101:1-2020071422194420444798
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yeh, Mei-Chun
- Tse, Brian W. C.
- Fletcher, Nicholas L.
- Houston, Zachary H.
- Lund, Maria
- Volpert, Marianna
- Stewart, Chelsea
- Sokolowski, Kamil A.
- Jeet, Varinder
- Thurecht, Kristofer J.
- Campbell, Douglas H.
- Walsh, Bradley J.
- Nelson, Colleen C.
- Russell, Pamela J.
- SpringerLink (Online service)
Other Objects (12)
Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
Correction to: Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Investigation of models with temporal and spatial interference in image based dosimetry of 177Lu-labelled radioligand therapies
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
Labelled love
Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
Correction to: Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Investigation of models with temporal and spatial interference in image based dosimetry of 177Lu-labelled radioligand therapies
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
Labelled love
Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
Correction to: Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Investigation of models with temporal and spatial interference in image based dosimetry of 177Lu-labelled radioligand therapies
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile